Investor Alert

New York Markets Open in:

Inovio Pharmaceuticals Inc.



After Hours

 --Quotes are delayed by 20 min

Oct 27, 2021, 7:59 p.m.





+0.03 +0.44%


Volume 26,773

Quotes are delayed by 20 min


Previous close

$ 6.84

$ 6.79


-0.05 -0.73%

Day low

Day high




52 week low

52 week high




Annual Financials for Inovio Pharmaceuticals Inc.

Operating Activities

Fiscal year is January-December. All values USD millions. 20162017201820192020 5-year trend
Net Income before Extraordinaries (73.74M)(88.21M)(96.97M)(120.55M)(167.47M)
Depreciation, Depletion & Amortization 3.09M3.47M5M5.52M4.63M
Depreciation and Depletion 1.71M1.85M3.75M4.45M4.08M
Amortization of Intangible Assets 1.38M1.62M1.25M1.07M547,081
Deferred Taxes & Investment Tax Credit (849)(150,027)-5,397-
Deferred Taxes (849)(150,027)-5,397-
Investment Tax Credit -----
Other Funds 8.63M22.39M13.71M20.72M55.94M
Funds from Operations (62.03M)(62.5M)(78.26M)(94.31M)(106.91M)
Extraordinaries -----
Changes in Working Capital (529,433)(713,119)4.71M(3.54M)(71.07M)
Receivables (9.24M)10.08M2.43M2.02M(17.02M)
Accounts Payable 7.28M2.68M601,256(4.59M)3.25M
Other Assets/Liabilities (2.34M)(15.72M)5.01M641,981(63.27M)
Net Operating Cash Flow (62.56M)(63.21M)(73.55M)(97.85M)(177.98M)

Investing Activities

20162017201820192020 5-year trend
Capital Expenditures (3.94M)(10.29M)(2.09M)(987,926)(1.52M)
Capital Expenditures (Fixed Assets) (3.94M)(10.29M)(2.09M)(987,926)(1.52M)
Capital Expenditures (Other Assets) -----
Net Assets from Acquisitions -----
Sale of Fixed Assets & Businesses ---2.96M2.38M
Purchase/Sale of Investments 19.21M(18.54M)44.5M(8.06M)(54.5M)
Purchase of Investments (57.32M)(95.7M)(88.16M)(100.95M)(157.62M)
Sale/Maturity of Investments 76.53M77.16M132.66M92.89M103.12M
Other Uses ----(2.77M)
Other Sources 1M1M---
Net Investing Cash Flow 16.27M(27.83M)42.42M(6.08M)(56.42M)

Financing Activities

20162017201820192020 5-year trend
Cash Dividends Paid - Total -----
Common Dividends -----
Preferred Dividends -----
Change in Capital Stock 7.94M95.69M31.04M9.09M466.76M
Repurchase of Common & Preferred Stk. -----
Sale of Common & Preferred Stock 7.94M95.69M31.04M9.09M466.76M
Proceeds from Stock Options 6.3M94.35M29.23M9.09M454.49M
Other Proceeds from Sale of Stock 1.64M1.34M1.81M-12.27M
Issuance/Reduction of Debt, Net ---94.13M171,620
Change in Current Debt -----
Change in Long-Term Debt ---94.13M171,620
Issuance of Long-Term Debt ---97.44M171,620
Reduction in Long-Term Debt ---(3.31M)-
Other Funds (149,559)--(780,406)(4.03M)
Other Uses (149,559)--(780,406)(4.03M)
Other Sources -----
Net Financing Cash Flow 7.79M95.69M31.04M102.44M462.9M
Exchange Rate Effect ----27,205
Miscellaneous Funds -----
Net Change in Cash (38.5M)4.65M(92,946)(1.5M)228.53M
Free Cash Flow (66.49M)(73.5M)(75.64M)(98.84M)(179.5M)
Link to MarketWatch's Slice.